Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Georgiadis

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Rheumatology|March 24, 2026
Subclinical atherosclerosis in patients with undifferentiated connective tissue disease: comparison with rheumatoid arthritisGeorgios V Papamichail, Nikolaos A Georgiadis, Vasileios G Xydis, et al.
Gene Therapy|December 17, 2009
AAV-mediated knockdown of peripherin-2 in vivo using miRNA-based hairpinsA Georgiadis, M Tschernutter, J W B Bainbridge, et al.
Gene Therapy|November 25, 2011
Absence of ocular malignant transformation after sub-retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53-deficient miceK S Balaggan, Y Duran, A Georgiadis, et al.
Toxicology Letters|September 28, 2011
Time-series analysis of gene expression profiles induced by nitrosamides and nitrosamines elucidates modes of action underlying their genotoxicity in human colon cellsDennie G A J Hebels, Karen J J Brauers, Marcel H M van Herwijnen, et al.
Journal of Colloid and Interface Science|December 16, 2019
Relationship between wetting and capillary pressure in a crude oil/brine/rock system: From nano-scale to core-scaleM Rücker, W-B Bartels, G Garfi, et al.
Gene Therapy|July 12, 2024
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|September 23, 2016
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|July 27, 2018
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|July 29, 2003
Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retinaJ W B Bainbridge, A Mistry, F C Schlichtenbrede, et al.
Nature Communications|April 21, 2022
Lateral gain is impaired in macular degeneration and can be targeted to restore vision in miceM Rizzi, K Powell, M R Robinson, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Rheumatology|March 24, 2026
Subclinical atherosclerosis in patients with undifferentiated connective tissue disease: comparison with rheumatoid arthritisGeorgios V Papamichail, Nikolaos A Georgiadis, Vasileios G Xydis, et al.
Gene Therapy|December 17, 2009
AAV-mediated knockdown of peripherin-2 in vivo using miRNA-based hairpinsA Georgiadis, M Tschernutter, J W B Bainbridge, et al.
Gene Therapy|November 25, 2011
Absence of ocular malignant transformation after sub-retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53-deficient miceK S Balaggan, Y Duran, A Georgiadis, et al.
Toxicology Letters|September 28, 2011
Time-series analysis of gene expression profiles induced by nitrosamides and nitrosamines elucidates modes of action underlying their genotoxicity in human colon cellsDennie G A J Hebels, Karen J J Brauers, Marcel H M van Herwijnen, et al.
Journal of Colloid and Interface Science|December 16, 2019
Relationship between wetting and capillary pressure in a crude oil/brine/rock system: From nano-scale to core-scaleM Rücker, W-B Bartels, G Garfi, et al.
Gene Therapy|July 12, 2024
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|September 23, 2016
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|July 27, 2018
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|July 29, 2003
Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retinaJ W B Bainbridge, A Mistry, F C Schlichtenbrede, et al.
Nature Communications|April 21, 2022
Lateral gain is impaired in macular degeneration and can be targeted to restore vision in miceM Rizzi, K Powell, M R Robinson, et al.
Pageof 4